Insider buying last 90 days
No open-market insider purchases were filed for ISRG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Intuitive Surgical shares rose this week after election results confirmed Democratic majorities in the House and Senate, lifting several healthcare names including ISRG. The company also announced that Aaron Martin, President of Insurance at Humana, will join its board effective 1 January 2027, with a prorated $70,000 annual cash retainer and an initial restricted stock unit grant targeted at $93,333. Separately, commentary this week noted ISRG trades at a P/E multiple of 51.6 times earnings, the highest among healthcare peers listed, which it attributes to the company's operating margin and revenue growth.
ISRG closed at $482.10, up 9.4%, sitting above both its 50-day average of $406.25 and 200-day average of $431.84. The GekkoIndex reads 42.3, placing the stock in the Distribution zone, down 4.3 over the past five readings. Price sits 30.4% above Gekko Fair Value of $369.64.
The next earnings date falls on 28 January 2027, 84 days away, outside a typical 20-trading-day holding window. Smart money activity in the last 90 days shows 4 Congressional buys and 0 sales, alongside 2 billionaire holders and 2 trailblazer holders. Seasonality from this point in the calendar has averaged a 5.1% return over the next 20 trading days across 5 years, rising in 4 of them. A Form 4 filing from VP Corporate Controller Fredrik Widman and a Form 8-K dated 2 November round out recent disclosures. The gap to Gekko Fair Value bears watching given the current Distribution reading.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Intuitive Surgical scores 3 supportive, 1 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed2 headwinds
Averages disagree
Close $482.10 sits between the 50-day ($406.25) and 200-day ($431.84) averages, or the averages disagree.
See the chart42.3, Distribution
Reading 42.3 is in the Distribution zone.
See the GekkoIndex30.4% above
Price is 30.4% above Gekko Fair Value (more than 5% above).
See fair valueLeans bullish
Last 90 days: Congress 4 buys / 0 sales.
See smart moneyReports in 84 days
Next report Jan 28, 2027, 84 days away — outside a typical 20-trading-day hold.
See earnings+5.1% on average
From this point in the calendar, the next 20 trading days averaged +5.1% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Intuitive Surgical closed at $482.10 on Nov 4, 2026, −11.4% over the past year, inside a 52-week range of $328.57 to $603.88.
Use the left and right arrow keys to read daily values.
Put ISRG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Intuitive Surgical designs, builds, and sells advanced medical devices aimed at making surgery less invasive for patients. Its best-known product is the da Vinci Surgical System, used to perform complex procedures through small incisions. The company also makes the Ion endoluminal system, which supports diagnostic work such as minimally invasive lung biopsies.
Beyond its two core systems, the company sells related instruments like staplers, energy devices, and other core components used alongside its equipment. It also provides training so medical staff can operate its technology properly, along with ongoing support such as installation, repair, and maintenance services. In addition, it builds digital tools meant to connect its systems and give hospitals data to help run more efficiently. Its customers are medical professionals and healthcare facilities in the United States and other countries.
Intuitive Surgical was founded in 1995 and is headquartered in Sunnyvale, California. Its shares are listed on the NASDAQ under the ticker ISRG.
Intuitive Surgical’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 42.3, in the Distribution zone, down 4.3 points over five sessions.
Down 4.3 points over five sessions, from the Neutral zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 34 | +0.9% | +2.8% | ||
| Accumulation | 250 | −0.4% | +0.4% | ||
| Neutral | 367 | +0.7% | +0.7% | ||
| Distribution (current zone) | 45 | −0.7% | +1.1% | ||
| Selling | 1 | Too few readings yet | |||
Average ISRG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
Intuitive Surgical trades 30.4% above Gekko Fair Value of $369.64, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Intuitive Surgical shares are worth, recalculated every trading day.
$369.64
Gekko Fair Value, Nov 4, 2026
30.4% Overvalued
At the end of Aug 2026 the price was 18.5% above the estimate.
No open-market insider purchases were filed for Intuitive Surgical, and members of Congress disclosed 4 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ISRG in the last 90 days.
From Form 4 filings, dated to when each was filed.
4trades disclosed: 4 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 25 |
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 11 |
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 4 |
| Michael McCaul House, TX, purchase | $15,001 - $50,000 | Oct 16 traded Aug 7 |
From congressional disclosures, which report amounts as ranges.
Intuitive Surgical has been buying back its own shares.
From company filings.
4of the funds Gekko tracks hold ISRG.
Intuitive Surgical reports on Jan 28, 2027, after the close (84 days away), and beat the EPS estimate in 8 of its last 8 reports.
Jan 28, 2027
Expected after the close, 84 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 20, 2026 | $3.00 est $2.65 | $3.05B est $2.91B | −1.2% |
| Jul 16, 2026 | $2.80 est $2.02 | $2.89B est $2.83B | −11.2% |
| Apr 21, 2026 | $2.50 est $2.12 | $2.77B est $2.62B | +3.9% |
| Jan 22, 2026 | $2.53 est $2.27 | $2.87B est $2.76B | +0.1% |
| Oct 21, 2025 | $2.40 est $1.99 | $2.51B est $2.41B | +15.0% |
| Jul 22, 2025 | $2.19 est $1.93 | $2.44B est $2.35B | −2.7% |
| Apr 22, 2025 | $1.81 est $1.74 | $2.25B est $2.19B | +4.2% |
| Jan 23, 2025 | $2.21 est $1.76 | $2.41B est $2.25B | −4.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Intuitive Surgical is $482.63, +0.1% from the last close, from 19 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 19 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 21 | Barclays | $500 | +3.7% |
| Oct 21 | Robert W. Baird | $550 | +14.1% |
| Oct 21 | Stifel Nicolaus | $550 | +14.1% |
| Oct 21 | Oppenheimer | $500 | +3.7% |
| Oct 21 | Raymond James | $480 | −0.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Intuitive Surgical averaged +5.1% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.7% | 3 of 5 |
| Next 10 trading days | +4.8% | 4 of 5 |
| Next 15 trading days | +5.3% | 4 of 5 |
| Next 20 trading days | +5.1% | 4 of 5 |
| Next 30 trading days | +6.1% | 4 of 5 |
For scale, ISRG’s typical 20-trading-day move in either direction is about 6.5%.
Intuitive Surgical’s market cap is $170.3B, with a P/E ratio of 52.8 and revenue of $11.58B over the last twelve months.
Coverage of Intuitive Surgical this week reads positive: 10 positive, 6 neutral and 6 negative headlines.
Intuitive Surgical’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 14.5% above |
| ABTAbbott Laboratories | Distribution | 8.0% below |
| DHRDanaher | Neutral | 3.6% above |
| MDTMedtronic | Neutral | 16.0% below |
| SYKStryker | Distribution | 6.5% above |
| BSXBoston Scientific | Neutral | 26.8% below |
A peer links to its own page where one exists.
Intuitive Surgical’s market cap is $170.3B at the Nov 4, 2026 close of $482.10, with 353.3M shares outstanding. The shares trade on a P/E ratio of 52.8.
The consensus analyst 12-month price target for Intuitive Surgical is $482.63, +0.1% from the last close. Of the 19 firms that rated the stock in the last 90 days, 18 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Intuitive Surgical is overvalued: the Nov 4, 2026 close of $482.10 is 30.4% above Gekko Fair Value of $369.64. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Intuitive Surgical is expected to report on Jan 28, 2027, after the market closes (84 days away). Analysts expect earnings of $2.97 per share on revenue of $3.24B. Intuitive Surgical beat the earnings estimate in 8 of its last 8 reports, moving 5.3% on average across the report.
Intuitive Surgical’s 52-week high is $603.88 and its 52-week low is $328.57; it closed at $482.10 on Nov 4, 2026, −11.4% over the past year. Over the last five years the shares peaked at $616.00 on Jan 23, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (smart money, earnings risk and seasonality), 1 as mixed (trend) and 2 as headwinds (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.